PROGNOSTIC VALUE OF SERUM HIGH SENSITIVITY C-REACTIVE PROTEIN IN PATIENTS WITH PERIODONTITIS AND DIABETES MELLITUS TYPE 2 AFTER NON-SURGICAL PERIODONTAL TREATMENT

Association between GCF Sclerostin Level and Haemoglobin A1c in Stage III Periodontitis Patients with Controlled and Uncontrolled Type 2 Diabetes Mellitus: A Case-Control Study

Hepcidin Level Changes in Type 2 Diabetes

Study of Periodontal Diseases and Risk Factors in Diabetic Patients

Evaluation of Serum Interleukin-10 and Matrix Metalloproteinase-9 Levels as Predictors of Glycemic Alteration in Type 2 Diabetes Mellitus in Patients with Periodontitis

Serum Ferritin and Soluble Transferrin Receptors in Type II Diabetic Patients: Correlation with TNF-αas a Marker of Inflammation

ENDOCAN: A NOVEL BIOMARKER IN GINGIVAL CREVICULAR FLUID IN PERIODONTITIS PATIENTS WITH OR WITHOUT TYPE 2 DIABETES MELLITUS [A CROSS-SECTIONAL STUDY]

INCREASED LEVELS OF SALIVARY INSULIN-LIKE GROWTH FACTOR-1 (IGF-I) AND INSULIN LIKE GROWTH FACTOR BINDING PROTEINS-1 AND 3 (IGFBP-I AND IGFBP-3) IN PATIENTS WITH PERIODONTITIS

IMPACT OF NON-SURGICAL PERIODONTAL THERAPY ON VISFATIN LEVEL IN GINGIVAL CREVICULAR FLUID OF TYPE II DIABETIC PATIENTS WITH PERIODONTITIS

Effect of non-surgical periodontal treatment on crevicular levels of Chemerin and Fibroblast growth factor 21 in controlled type 2 diabetic and non-diabetic patients both with periodontitis and their glycemic control. A clinical trial